Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

返回 Agenda

Session 5: Clarity in Clinical Trials: Unlocking the Potential of Plain Language Summaries for Patients and the Public

Session Chair(s)

Francine Lane, MBA

Senior Director of Product Management

Citeline, United States

Session 5: Clarity in Clinical Trials: Unlocking the Potential of Plain Language Summaries for Patients and the Public

Speaker(s)

Navigating EU CTR: Mastering Effective Lay Protocol Synopses (LPS) and Plain Language Summary (PLS) Development

Representative Invited

Merck Sharp & Dohme LLC, United States

The Value of Plain Language Writing in Clinical Research Operations and Medical Communication

Representative Invited

Daiichi Sankyo, Inc. , United States

Global Clinical Trial Disclosure and Data Transparency Conference

Session 5: Clarity in Clinical Trials: Unlocking the Potential of Plain Language Summaries for Patients and the Public

Session Chair(s)

Francine Lane, MBA

Speaker(s)

Navigating EU CTR: Mastering Effective Lay Protocol Synopses (LPS) and Plain Language Summary (PLS) Development

The Value of Plain Language Writing in Clinical Research Operations and Medical Communication

获得信息并保持参与